TRO40303 Uses, Dosage, Side Effects and more
TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction).
| Trade Name | TRO40303 |
| Generic | TRO40303 |
| Type | |
| Formula | C26H47NO2 |
| Weight | Average: 405.667 Monoisotopic: 405.360679757 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
